NON CONTROLLING INTEREST (Details) - USD ($) |
3 Months Ended | |
|---|---|---|
Mar. 31, 2023 |
Mar. 31, 2022 |
|
| Net loss attributable to the non-controlling interest | $ (934) | $ (551) |
| BioCorRx Pharmaceuticals, Inc [Member] | ||
| Net loss | $ (1,447) | $ (2,276) |
| Average Non-controlling interest percentage of profit/losses | 24.20% | 24.20% |
| Net loss attributable to the non-controlling interest | $ (350) | $ 551 |
| Joseph DeSanto MD [Member] | ||
| Net loss | $ (1,668) | |
| Average Non-controlling interest percentage of profit/losses | 35.00% | |
| Net loss attributable to the non-controlling interest | $ (584) | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|